MARKET

DAWN

Day One Biopharmaceuticals, Inc.
DAWN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-20.7039
14.02
5.03
2,224,784,658.57
Day One Biopharmaceuticals Completes Merger, Goes Private
TipRanks · 04/23 13:21
Day One Biopharmaceuticals asks Nasdaq to delist shares after merger closes
PUBT · 04/23 12:54
Servier completes acquisition of Day One for $21.50 per share
PUBT · 04/23 12:33
SERVIER COMPLETES THE ACQUISITION OF DAY ONE BIOPHARMACEUTICALS
Reuters · 04/23 12:30
NASDAQ TRADE HALT <DAWN.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 04/22 23:50
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Seeking Alpha · 04/20 15:55
Weekly Report: what happened at DAWN last week (0413-0417)?
Weekly Report · 04/20 09:24
Weekly Report: what happened at DAWN last week (0406-0410)?
Weekly Report · 04/13 09:25
More

Webull offers Day One Biopharmaceuticals, Inc. stock information, including NASDAQ: DAWN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DAWN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DAWN stock methods without spending real money on the virtual paper trading platform.